A GLP-1 reset is not some mythical protocol that magically restores everything overnight
Thus, treatment with AT-7687 and liraglutide reduced appetite but, in this first preclinical study, the effect of the GIP receptor antagonist could not be separated from the GLP-1 receptor agonist alone (51)
Quick answer: when GLP 1 therapy is and is not the right tool GLP 1 therapy can be a strong option when menopause weight gain is tied to insulin resistance, appetite dysregulation, visceral fat gain, or repeated plateaus despite consistent habits
However, some studies didnt find any difference between Ashwagandha and placebo with both decreasing stress with similar magnitude [26, 27]
Rajan Journal of Dietary Supplements.2021
High amounts of visceral fat are associated with chronic conditions like obesity, type 2 diabetes, and heart disease